# A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1

> **NCT01373606** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 8 (actual)

## Conditions studied

- Hepatorenal Syndrome Type 1

## Interventions

- **DRUG:** Terlipressin

## Key facts

- **NCT ID:** NCT01373606
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-03
- **Final completion:** 2009-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2012-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01373606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01373606, "A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01373606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*